968.21% More Valeritas Holdings Inc (NASDAQ:VLRX) Shorted Shares

June 27, 2018 - By Jeanette Garcia

It was registered an increase on Valeritas Holdings Inc (NASDAQ:VLRX)’s shorted shares with 968.21%. It was announced in June by FINRA the 161,300 shorted shares on VLRX. Previously was reported up change of 968.21% from 15,100 shares. Former VLRX’s position will need 0 days to restore. It has 2.20 million average volume. Valeritas Holdings Inc float short is 6.82%.

The stock decreased 4.00% or $0.06 during the last trading session, touching $1.44.Valeritas Holdings, Inc. has volume of 561,423 shares. Since June 27, 2017 VLRX has declined 68.29% and is downtrending. The stock underperformed the S&P500 by 80.86%.

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes.The firm is valued at $35.58 million. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy.Currently it has negative earnings. The firm also develops h-Patch, a controlled delivery technology platform; Mini-Ject, a disposable needle-free injection system that delivers drugs ranging from small molecules to large proteins, as well as antibodies and vaccines; and Micro-Trans microneedle array patch technology to deliver drugs into the dermis layer of the skin.

For more Valeritas Holdings, Inc. (NASDAQ:VLRX) news brought out briefly go to: Benzinga.com, Nasdaq.com, Nasdaq.com, Streetinsider.com or Benzinga.com. The titles are as follows: “36 Stocks Moving In Monday’s Mid-Day Session” brought out on June 25, 2018, “Mid-Morning Market Update: Markets Open Lower; Carnival Cuts Profit Forecast” on June 25, 2018, “Valeritas ENABLE Study Demonstrates Significant Clinical Benefits of V-Go in Patients with Type 2 Diabetes Who …” with a publish date: June 25, 2018, “Pre-Open Movers 06/25: (XRM) (VLRX) (GTN) Higher; (SPHS) (MACK) (ATI) Lower (more…)” and the last “44 Biggest Movers From Yesterday” with publication date: June 26, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: